The effects of Atrasentan on sperm production and the function of the testicles in male subjects with Type 1 or 2 Diabetes and Nephropathy

Registry ID

EUCTR2016-000722-19

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

AbbVie Deutschland GmbH & Co. KG

Start date

2016-10-24

Completion date

2018-07-12

Last update

2026-08-16

Conditions

• Diabetic Nephropathy

Summary

Evaluate the effect of Atrasentan on spermatogenesis and testicular function in men with diabetic nephropathy.

Locations

• , , Germany
• , , Spain

Related clinical trials

• Lactoferrin Supplementation in Diabetic Nephropathy
• Type 2 Diabetes and Associated Factors in Mexico
• Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population
• The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
• Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
• Raman Spectroscopy Diagnosis of Kidney Diseases

View on source registry